{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:37:28Z","timestamp":1784590648570,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.044","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T01:02:04Z","timestamp":1672794124000},"page":"1081-1093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Double and quadruple deletion mutant of EHV-1 is highly attenuated and induces optimal immune response"],"prefix":"10.1016","volume":"41","author":[{"given":"Venkataramireddy","family":"Balena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Sansanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhushikesh","family":"Khetmalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashwina","family":"Madhwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Bernela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Supriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pavulraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.N.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.12.044_b0005","unstructured":"WOAH. Equine rhinopneumonitis (Infection with equid herpesvirus 1 and 4 in OIE Terrestrial Manual 2018; 1320-1332. https:\/\/www.woah.org\/fileadmin\/Home\/eng\/Health_standards\/tahm\/3.06.09_ EQUINE_RHINO.pdf."},{"key":"10.1016\/j.vaccine.2022.12.044_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fmicb.2021.662686","article-title":"The pathogenesis and immune evasive mechanisms of equine herpesvirus type 1","volume":"12","author":"Laval","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0015","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fmicb.2019.02668","article-title":"EHV-1: A constant threat to the horse industry","volume":"10","author":"Oladunni","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2014.05.023","article-title":"Equine herpesvirus type 1 pUL56 modulates innate responses of airway epithelial cells","volume":"464","author":"Hussey","year":"2014","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2022.105827","article-title":"Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?","author":"Hussey","year":"2022","journal-title":"The Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.044_b0030","doi-asserted-by":"crossref","DOI":"10.2174\/1874318808002010068","article-title":"Equine herpes virus-1: virus, immunity and vaccines","volume":"2","author":"Paillot","year":"2008","journal-title":"The Open Vet Sci J"},{"key":"10.1016\/j.vaccine.2022.12.044_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/viro.1996.0652","article-title":"The Equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence","volume":"226","author":"Osterrieder","year":"1996","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/viro.1996.0138","article-title":"The Equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture","volume":"217","author":"Osterrieder","year":"1996","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0045","doi-asserted-by":"crossref","first-page":"9806","DOI":"10.1128\/JVI.72.12.9806-9817.1998","article-title":"The Equine herpesvirus 1 IR6 protein that colocalizes with nuclear lamins is involved in nucleocapsid egress and migrates from cell to cell independently of virus infection","volume":"72","author":"Osterrieder","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/viro.1997.8984","article-title":"An Equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses","volume":"242","author":"Matsumura","year":"1998","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0168-1702(02)00245-9","article-title":"Contribution of gene products encoded within the unique short segment of Equine herpesvirus 1 to virulence in a murine model","volume":"90","author":"Frampton","year":"2002","journal-title":"Virus Res"},{"issue":"18","key":"10.1016\/j.vaccine.2022.12.044_b0060","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1128\/JVI.00986-16","article-title":"Immunization with Attenuated Equine herpesvirus 1 Strain KyA induces innate immune responses that protect mice from lethal challenge","volume":"90","author":"Kim","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0065","doi-asserted-by":"crossref","unstructured":"Yan S, Huang B, Bai X, Zhou Y, Guo L, Wang T, Shan Y, Wang Y, Tan F and Tian K. Construction and immunogenicity of a recombinant pseudorabies virus variant with TK\/gI\/gE\/11k\/28k deletion.Front. Vet. Sci. 2021; 8 https:\/\/doi:10.3389\/fvets.2021.797611.","DOI":"10.3389\/fvets.2021.797611"},{"key":"10.1016\/j.vaccine.2022.12.044_b0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1997.8483","article-title":"An Equine herpesvirus 1 gene 71 deletant is attenuated and elicits a protective immune response in mice","volume":"231","author":"Marshall","year":"1997","journal-title":"Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.12.044_b0075","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1292\/jvms.001439","article-title":"Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain","volume":"71","author":"Tsujimura","year":"2009","journal-title":"J Vet Med Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2022.12.044_b0080","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/JVI.00032-15","article-title":"Equine herpesvirus 1 multiply inserted transmembrane protein pUL43 cooperates with pUL56 in down regulation of cell surface major histocompatibility complex class I","volume":"89","author":"Huang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0085","first-page":"397","article-title":"Differentiation of Indian Isolates of Equine Herpes Virus (EH V-1) by Restriction Endonuclease Digestion","volume":"2000","author":"Singh","year":"2002","journal-title":"Indian J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.044_b0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00705-016-3097-z","article-title":"Genetic characterization of equine herpesvirus 1 isolates from abortion outbreaks in India","volume":"162","author":"Anagha","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2144\/000112096","article-title":"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli","volume":"40","author":"Tischer","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2022.12.044_b0100","unstructured":"Poulsen TS. Purification of BAC DNA. InBacterial artificial chromosomes. Humana Press; 2004 (pp. 91-100). 10.1385\/1-59259-752-1:091."},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.044_b0105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/v7020522","article-title":"Comparative analysis of glycoprotein B (gB) of Equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission","volume":"7","author":"Spiesschaert","year":"2015","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.044_b0110","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/JVI.06555-11","article-title":"Glycoproteins D of Equine herpesvirus type 1 (EHV-1 and EHV-4 determine cellular tropism independently of integrins","volume":"86","author":"Azab","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0115","unstructured":"Luna LG. Manual of histologic methods of the armed forces institute of pathology. McGraw-Hill; 1968."},{"key":"10.1016\/j.vaccine.2022.12.044_b0120","first-page":"1","article-title":"Immunohistochemical diagnosis of Equineherpesvirus-1 infection employing microwave irradiation for reducing the processing time","volume":"28","author":"Virmani","year":"2004","journal-title":"Ind J Vet Pathol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.12.044_b0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1292\/jvms.68.1029","article-title":"Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models","volume":"68","author":"Tsujimura","year":"2006","journal-title":"J Vet Med Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2022.12.044_b0130","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/JVI.06994-11","article-title":"Identification and characterization of Equine herpesvirus type 1 pUL56 and its role in virus-induced down regulation of major histocompatibility complex class I","volume":"86","author":"Ma","year":"2012","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.12.044_b0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/v12090999","article-title":"Equine Herpesvirus type 1 modulates cytokine and chemokine profiles of mononuclear cells for efficient dissemination to target organs","volume":"12","author":"Pavulraj","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.044_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.01.032","article-title":"Identification and characterization of the pseudorabies virus UL43 protein","volume":"334","author":"Klupp","year":"2005","journal-title":"Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.044_b0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1099\/vir.0.18612-0","article-title":"Down-regulation of MHC class I expression by equine herpesvirus-1","volume":"84","author":"Rappocciolo","year":"2003","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.12.044_b0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1590\/1414-431x20154243","article-title":"A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain","volume":"48","author":"Weiss","year":"2015","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2022.12.044_b0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fvets.2017.00211","article-title":"Comparative genomic sequencing and pathogenic properties of equine herpesvirus 1 KyA and RacL11","volume":"4","author":"Shakya","year":"2017","journal-title":"Front Vet Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.044_b0160","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1099\/0022-1317-71-5-1131","article-title":"The pathogenesis of Equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection","volume":"71","author":"Awan","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-1702(98)00092-6","article-title":"Primary and secondary infection of mice with equine herpesvirus 1, strain HVS25A","volume":"57","author":"Walker","year":"1998","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.044_b0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2567.1998.00451.x","article-title":"In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice","volume":"93","author":"Bartels","year":"1998","journal-title":"Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2022.12.044_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-1135(99)00056-5","article-title":"Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review","volume":"68","author":"Walker","year":"1999","journal-title":"Vet Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.12.044_b0180","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nri2802","article-title":"Immunity and immunopathology to viruses: what decides the outcome?","volume":"10","author":"Rouse","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2022.12.044_b0185","doi-asserted-by":"crossref","unstructured":"Galani IE and Andreakos E. Neutrophils in viral infections: Current concepts and caveats. J. Leukoc. Biol. 2015; 98(4): 557-564. https:\/\/DOI: 10.1189\/jlb.4VMR1114-555R.","DOI":"10.1189\/jlb.4VMR1114-555R"},{"issue":"36","key":"10.1016\/j.vaccine.2022.12.044_b0190","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2005.03.048","article-title":"Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1","volume":"23","author":"Paillot","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.044_b0195","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jviromet.2008.05.008","article-title":"Development of an ELISA to detect Sin Nombre virus-specific IgM from deer mice (Peromyscus maniculatus)","volume":"151","author":"Bego","year":"2008","journal-title":"J Virol Methods"},{"issue":"11","key":"10.1016\/j.vaccine.2022.12.044_b0200","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/CVI.00374-14","article-title":"Influenza virus-specific neutralizing IgM antibodies persist for a lifetime","volume":"21","author":"Skountzou","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.044_b0205","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1099\/0022-1317-69-4-847","article-title":"Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides","volume":"69","author":"McKendall","year":"1988","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.044_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1297-9716-42-23","article-title":"Evaluation of immune responses following infection of ponies with an EHV-1 ORF1\/2 deletion mutant","volume":"42","author":"Hussey","year":"2011","journal-title":"Vet Res"},{"issue":"11","key":"10.1016\/j.vaccine.2022.12.044_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206679","article-title":"The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses","volume":"13","author":"Wimer","year":"2018","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:33Z","timestamp":1759404153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015699"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double and quadruple deletion mutant of EHV-1 is highly attenuated and induces optimal immune response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}